RoseiE. AgabitiBrownJ. J.LeverD. F.RobertsonA. S.RobertsonJ. I. S.TrustP. M. (1976). Treatment of phaeochromocytoma and of clonidine-withdrawal hypertension with labetalol. British Journal of Clinical Pharmacology, 3, Suppl. 3, 743.
2.
AhlquistR. P. (1948). A study of adrenotropic receptors. American Journal of Physiology, 153, 586.
3.
AmerM. S. (1977). Mechanism of action of β-blockers in hypertension. Biochemical Pharmacology, 26, 171.
4.
BeilinL. J.Juel-JenonB. E. (1972). Alpha- and beta- adrenergic blockade in hypertension. Lancet, 1, 979.
5.
DargieH. J.DolleryC. J.DanielJ. (1976). Labetalol in resistant hypertension. British Journal of Clinical Pharmacology, 3, Suppl. 3, 751.
6.
EdwardsR. C.RafteryE. B. (1976). Haemodynamic effects of long-term oral labetalol. British Journal of Clinical Pharmacology, 3, Suppl. 3, 733.
7.
FreisE. D. (1960). Hemodynamics of hypertension. Physiological Reviews, 40, 27.
8.
GoldbergD. D.RafteryE. B.StottF. D. (1978). A study of untreated hypertensive subjects by means of continuous intra-arterial blood pressure recording. British Heart Journal, in press.
9.
JohnsonB. F.La BrooyJ.Munro-FaureA. D. (1976). The anti-hypertensive efficacy of combined alpha- and beta- adrenoreceptor blockade with phentolamine -oxprenolol or with labetalol (Am 5158). Clinical Science and Molecular Medicine, 51, Suppl. 3, 505S.
10.
KochG. (1976). Combined alpha- and beta- adrenoreceptor blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise. British Journal of Clinical Pharmacology, 3, Suppl. 3, 729.
11.
MajidP. A.MeeranM. K.BenaimM. E.SharmaB.TaylorS. H. (1974). Alpha- and beta- adrenergic receptor blockage in the treatment of hypertension. British Heart Journal, 36, 588.
12.
MoyerJ. H.CaplovitzC. (1953). The clinical results of oral and parenteral administration of imidazoline hydrochloride (Rogitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects. American Heart Journal, 45, 602.
13.
MoranV. C. (1966). Adrenergic receptor drugs and the cardiovascular system. Modern Concepts of Cardiovascular Disease, 35, 93.
14.
PrichardB. N. C. (1974). Beta-adrenergic receptor blocking drugs in angina pectoris. Drugs, 7, 55.
15.
PrichardB. N. C.BoakesA. J. (1976). Labetalol in long-term treatment of hypertension. British Journal of Clinical Pharmacology, 3, Suppl. 3, 743.
16.
PrichardB. N. C.GillamP. M. S. (1969). Treatment of hypertension with propranolol. British Medical Journal, 1, 7.
17.
RichardsD. A. (1976). Pharmacological effects of labetalol in man. British Journal of Clinical Pharmacology, 3, Suppl. 3, 721.
18.
RichardsD. A.WoodingsE. P.PrichardB. N. C. (1978). Circulatory and alpha-adrenoreceptor blocking effects of phentolamine. British Journal of Clinical Pharmacology, 5, 507.
19.
TaylorS. H.DonaldK. W.BishopJ. M. (1957). Circulatory studies in hypertensive patients at rest and during exercise. Clinical Science, 16, 351.
20.
WilliamsE. M. V.RaineA. E. G. (1974). Effects of prolonged beta-receptor blockade on dry weight and electrophysiological responses of rabbit hearts. Lancet, 2, 1048.
21.
WilliamsE. M. V.RaineA. E. G.CabreraA. A.WhyteJ. M. (1975). The effects of prolonged beta-adrenoreceptor blockade on heart weight and cardiac intracellular potential in rabbits. Cardiovascular Research, 9, 579.
22.
ZachariasF. J.CowenK. J. (1970). Controlled trial of propranolol in hypertension. British Medical Journal, 1, 471.
